Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (2): 83-89.doi: 10.6040/j.issn.1671-7554.0.2023.0961
• Clinical Medicine • Previous Articles
LIU Huanjun, GUO Shuxia, SHI Ruiping, ZHANG Wenbang, ZHANG Xiaojuan
CLC Number:
| [1] 曾宇竹.成人朗格汉斯细胞组织细胞增生症12例临床分析并文献复习[D]. 重庆: 重庆医科大学, 2021. [2] 刘鑫. 成人朗格汉斯细胞组织细胞增生症伴尿崩症1例并文献复习[D]. 大连: 大连医科大学, 2019. [3] 刘文婷. 成人朗格汉斯组织细胞增多症3例并文献复习[D]. 济南: 山东大学, 2016. [4] 范锦. 成人朗格汉斯细胞组织细胞增生症4例报道并文献复习[D]. 济南: 山东大学, 2014. [5] 杨雪良, 王志红, 曹永彬, 等. 成人朗格汉斯细胞组织细胞增生症3例并文献复习[J]. 军医进修学院学报, 2012, 33(3): 288-290. YANG Xueliang, WANG Zhihong, CAO Yongbin, et al. Adult Langerhans cell histiocytosis: a report of 3 cases and literature review[J]. Journal of Chinese PLA Postgraduate Medical School, 2012, 33(3): 288-290. [6] 李业梅, 俞小卫, 杨明夏, 等. 成人朗格汉斯细胞组织细胞增多症二例[J]. 中华结核和呼吸杂志, 2015, 38(4): 311-313. [7] Choi YS, Lim JS, Kwon W, et al. Pulmonary Langerhans cell histiocytosis in an adult male presenting with central diabetes insipidus and diabetes mellitus: a case report[J]. Tuberc Respir Dis(Seoul), 2015, 78(4): 463-468. [8] Mansour MJ, Mokbel E, Fares E, et al. Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report[J]. J Med Case Rep, 2017, 11(1): 272. doi: 10.1186/s13256-017-1428-7. [9] Perren F, Fankhauser L, Thievent B, et al. Late adult onset of Langerhans cell histiocytosis mimicking glioblastoma multiforme[J]. J Neurol Sci, 2011, 301(1-2): 96-99. [10] Podjasek JO, Loftus CG, Smyrk TC, et al. Adult-onset systemic Langerhans cell histiocytosis mimicking inflammatory bowel disease: the value of skin biopsy and review of cases of Langerhans cell histiocytosis with cutaneous involvement seen at the Mayo Clinic[J]. Int J Dermatol, 2014, 53(3): 305-311. [11] Minami M, Shima T, Kato K, et al. Successful treatment of adult Langerhans cell histiocytosis with intensified chemotherapy[J]. Int J Hematol, 2015, 102(2): 244-248. [12] Amini B, Kumar R, Wang WL. Soft tissue Langerhans cell histiocytosis with secondary bone involvement in extremities: evolution of lesions in two patients[J]. Skeletal Radiol, 2013, 42(9): 1301-1309. [13] Xie J, Li Z, Tang Y. Successful management of multiple-systemic Langerhans cell histiocytosis involving endocrine organs in an adult: a case report and review of literature[J]. Medicine(Baltimore), 2018, 97(26): e11215. doi: 10.1097/MD.0000000000011215. [14] Kim SS, Hong SA, Shin HC, et al. Adult Langerhans cell histiocytosis with multisystem involvement: a case report[J]. Medicine(Baltimore), 2018, 97(48): e13366. doi: 10.1097/MD.0000000000013366. [15] Wang BB, Ye JR, Li YL, et al. Multisystem involvement Langerhans cell histiocytosis in an adult: a case report[J]. World J Clin Cases, 2020, 8(20): 4966-4974. [16] Yuasa M, Fujiwara S, Oh I, et al. Rapidly progressing fatal adult multi-organ Langerhans cell histiocytosis complicated with fatty liver disease[J]. J Clin Exp Hematop, 2012, 52(2): 121-126. [17] Pankaj P, Gupta P, Pankaj N, et al. Multifocal, multisystem presentation of adult-onset Langerhans cell histiocytosis on 18F-fluorodeoxyglucose positron-emission tomography-computed tomography: a rare case report[J]. Indian J Nucl Med, 2022, 37(1): 78-82. [18] Araujo B, Costa F, Lopes J, et al. Adult langerhans cell histiocytosis with hepatic and pulmonary involvement[J]. Case Rep Radiol, 2015, 2015: 536328. doi: 10.1155/2015/536328. [19] Donadieu J, Bernard F, van Noesel M, et al. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study[J]. Blood, 2015, 126(12): 1415-1423. [20] Goyal G, Tazi A, Go RS, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults[J]. Blood, 2022, 139(17): 2601-2621. [21] Emile JF, Cohen-Aubart F, Collin M, et al. Histiocytosis[J]. Lancet, 2021, 398(10295): 157-170. [22] Wang W, Ge J, Ma H, et al. Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis[J]. Heliyon, 2023, 9(9): e19277. doi: 10.1016/j.heliyon.2023.e19277. [23] Evseev D, Osipova D, Kalinina I, et al. Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH[J]. Blood Adv, 2023, 7(18): 5246-5257. [24] Lian H, Cui L, Yang Y, et al. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis[J]. Pituitary, 2022, 25(1): 108-115. [25] Cantu MA, Lupo PJ, Bilgi M, et al. Optimal therapy for adults with Langerhans cell histiocytosis bone lesions[J]. PLoS One, 2012, 7(8): e43257. doi: 10.1371/journal.pone.0043257. [26] Tahir IM, Iqbal T, Jamil A, et al. Association of BCL-2 with oxidative stress and total antioxidant status in pediatric acute lymphoblastic leukemia[J]. J Biol Regul Homeost Agents, 2017, 31(4): 1023-1027. [27] Duan MH, Han X, Li J, et al. Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: a single-center retrospective study[J]. Leuk Res, 2016, 42: 43-46. doi: 10.1016/j.leukres.2016.01.012. [28] Minichino D, Lv K, Chu N, et al. BRAF-V600E utilizes posttranscriptional mechanisms to amplify LPS-induced TNFalpha production in dendritic cells in a mouse model of Langerhans cell histiocytosis[J]. J Leukoc Biol, 2022, 112(5): 1089-1104. [29] 乐张慧,孙建方. 单用沙利度胺治疗成人肛周单发朗格汉斯细胞组织细胞增生症1例[J]. 中国皮肤性病学杂志, 2021, 35(9): 1078-1079. [30] Wang JN, Liu T, Zhao AL, et al. Phase 2 study of oral thalidomide-cyclophosphamide-dexamethasone for recurrent/refractory adult Langerhans cell histiocytosis[J]. Leukemia, 2022, 36(6): 1619-1624. [31] Jan M, Sperling AS, Ebert BL. Cancer therapies based on targeted protein degradation- lessons learned with lenalidomide[J]. Nat Rev Clin Oncol, 2021, 18(7): 401-417. [32] Bigenwald C, Le Berichel J, Wilk CM, et al. BRAF(V600E)-induced senescence drives Langerhans cell histiocytosis pathophysiology[J]. Nat Med, 2021, 27(5): 851-861. [33] Kvedaraite E, Milne P, Khalilnezhad A, et al. Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology[J]. Sci Immunol, 2022, 7(78): eadd3330. doi: 10.1126/sciimmunol.add3330. [34] Heritier S, Emile JF, Barkaoui MA, et al. BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy[J]. J Clin Oncol, 2016, 34(25): 3023-3030. [35] Helias-Rodzewicz Z, Donadieu J, Terrones N, et al. Molecular and clinicopathologic characterization of pediatric histiocytosis[J]. Am J Hematol, 2023, 98(7): 1058-1069. |
| [1] | WANG Shao-Qing, LIU Yi-Hui, FU Ting-Ting, CHENG Jin-Yong, LIU Qiang. Classification of 31P MRS data for hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 42-46. |
| [2] | SONG Xiaoyu, LI Qian, WANG Lulu, WANG Xin, DONG Zhenhua, PANG Shuguang. Hormones combined with methimazole in the treatment of thyroid crisis with hepatitis B and liver failure: a case report [J]. Journal of Shandong University (Health Sciences), 2024, 62(1): 76-81. |
| [3] | ZHU Jinyu, GAO Shuai, WANG Kai. Clinical value of CONUT score in hepatitis B cirrhosis [J]. Journal of Shandong University (Health Sciences), 2023, 61(7): 72-77. |
| [4] | SONG Han, WANG Zhenhua, WEI Duoliang, XU Kai, LI Bowen, ZHAO Xin. Impacts of preoperative MELD grades on the postoperative early outcomes of 304 acute Standford type A aortic dissection patients [J]. Journal of Shandong University (Health Sciences), 2023, 61(5): 31-36. |
| [5] | LIU Xiaohan, SHI Hui, ZHAO Zhenjun. Effects of KLHL15 gene on the testis and liver of male mice [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 25-30. |
| [6] | XU Tianqi, CHANG Na, ZHANG Shuai, LI Sha, JIAO Bingxuan, YU Xinxin, WANG Ximing. Identification of carotid high-risk plaques by non-alcoholic fatty liver disease based on CTA [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 36-43. |
| [7] | ZHANG Hongyuan, GU Yongzhong. Vaginal delivery after myomectomy in the first trimester of pregnancy: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2023, 61(1): 69-73. |
| [8] | ZHANG Feng, WU Zhe, XU Jun, LIU Yulan. Changes of intestinal B lymphocytes in 6 mice with non-alcoholic fatty liver disease [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 67-73. |
| [9] | ZHENG Haotian, WANG Guanghui, ZHAO Xiaogang, WANG Yadong, ZENG Yukai, DU Jiajun. A prognostic risk model for LKB1 mutant lung adenocarcinoma based on aberrant DNA methylation sites [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 51-58. |
| [10] | LI Bo, LIU Jingfang, BAO Jinpeng, LI Xiangze, QIN Guangyang, TIAN Hu. Application value of three-dimensional visualization combined with indocyanine green fluorescence technique in laparoscopic hepatectomy in the treatment of 51 patients with primary liver cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 83-88. |
| [11] | SUN Rongrong, ZHANG Wenmiao, LI Dong, XIAO Biru, CHEN Qiuyue. Effects of admission time on labor duration and delivery mode among primiparas under new partogram [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 81-85. |
| [12] | XU Wenting, LI Jing, JIA Mingwang, PENG Fang, YANG Jialin. Clinical analysis of acute fatty liver of pregnancy in 63 cases [J]. Journal of Shandong University (Health Sciences), 2019, 57(5): 110-115. |
| [13] | SHAO Chunchun, ZHANG Yuan, HONG Fanzhen, XIAO Juan, LIU Huandi, JIA Hongying, ZHANG Yinghui. Hospitalization expenses and the influencing factors for scar uterine maternal subsequent delivery in a tertiary hospital of Shandong Province [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 88-92. |
| [14] | ZHU Yixin, FAN Xiaohui, CHEN Yan, LI Lingbing. Cooperative pH-sensitivity polyion complex micelles for co-delivery of doxorubicin and paclitaxel [J]. Journal of Shandong University (Health Sciences), 2018, 56(6): 21-28. |
| [15] | ZHANG Zhongyi, ZHANG Qi, JIE Yi, ZHOU Si, WU Haiyan, ZANG Ying, PAN Jingxue, WU Yuping, NA Xiaodong. Effects of stigma maydis polysaccharides on liver protection and glycometabolism in diabetic mice [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 52-57. |
|
||
